Home/Filings/4/0001493152-23-046389
4//SEC Filing

FR Capital Holdings, L.P. 4

Accession 0001493152-23-046389

CIK 0001603207other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 5:00 PM ET

Size

8.8 KB

Accession

0001493152-23-046389

Insider Transaction Report

Form 4
Period: 2023-12-26
Transactions
  • Sale

    Ordinary Shares, par value NIS 0.35 each

    2023-12-26$2.16/sh11,456$24,766978,022 total(indirect: See Footnote)
  • Sale

    Ordinary Shares, par value NIS 0.35 each

    2023-12-27$2.08/sh20,033$41,695957,989 total(indirect: See Footnote)
Footnotes (3)
  • [F1]FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of December 28, 2023, FRCV held 391,621 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 566,368 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
  • [F2]On December 26, 2023, FRCV sold 4,247 Ordinary Shares and FRCVIIIF sold 7,209 Ordinary shares, each at a weighted average price of $2.1618 per share. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]On December 27, 2023, FRCV sold 7,426 Ordinary Shares and FRCVIIIF sold 12,607 Ordinary shares, each at a weighted average price of $2.0813 per share. These shares were sold in multiple transactions at prices ranging from $1.9893 to $2.1665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Notable Labs, Ltd.

CIK 0001603207

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001776703

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:00 PM ET
Size
8.8 KB